Medicare Enrolled

Dr. Michelle Clermont, M.D.

Student in an Organized Health Care Education/Training Program · Atlanta, GA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
5671 PEACHTREE DUNWOODY RD STE 600, Atlanta, GA 30342
4042579000
In practice since 2013 (13 years)
NPI: 1174966204 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Clermont from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Clermont? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Clermont

Dr. Michelle Clermont is a student in an organized health care education/training program specialist in Atlanta, GA, with 13 years of NPI registration. Based on federal Medicare data, Dr. Clermont performed 1,527 Medicare services across 462 unique beneficiaries.

Between the years covered by Open Payments, Dr. Clermont received a total of $6,182 from 39 pharmaceutical and/or device companies across 352 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in student in an organized health care education/training program. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Clermont is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice ▲ Top 13% volume in GA $6,182 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,527
Medicare services
Top 13% in GA for student in an organized health care education/training program
462
Unique beneficiaries
$51
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~117 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
990 $26 $95
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
161 $89 $392
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
76 $94 $301
Upper GI endoscopy with biopsy
A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities.
53 $69 $600
Colonoscopy with biopsy
A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease.
49 $125 $793
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
44 $119 $507
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
38 $62 $210
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
33 $102 $400
Esophageal function monitoring via nasal tube
This procedure involves prolonged monitoring and recording of esophageal function using a nasal tube equipped with an electrode.
20 $43 $177
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
20 $136 $588
Colon polyp removal with endoscopic snare
This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination.
16 $205 $943
Upper endoscopy (EGD)
A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope.
15 $86 $408
Balloon dilation of esophagus, stomach, or upper small bowel, less than 3.0 cm
A procedure using a flexible endoscope to widen a narrowed section of the esophagus, stomach, or upper small bowel with a balloon that is less than 3.0 cm in length.
12 $110 $1,409
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
64.8% high complexity
7.7% medium
27.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$6,182
Total received (2019-2024)
Avg $1,030/year across 6 years
Top 6% in GA for student in an organized health care education/training program
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
352
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,182 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,192
2023
$1,197
2022
$942
2021
$1,528
2020
$282
2019
$41

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$486
Takeda Pharmaceuticals U.S.A., Inc.
$283
Janssen Biotech, Inc.
$266
Lilly USA, LLC
$221
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$125
AIMMUNE THERAPEUTICS, INC.
$114
Intercept Pharmaceuticals, Inc.
$101
VIVUS LLC
$94
Madrigal Pharmaceuticals
$83
Celgene Corporation
$69
Sandoz Inc.
$63
Celltrion USA Inc.
$57
Ipsen Biopharmaceuticals, Inc
$39
Phathom Pharmaceuticals, Inc.
$36
Ardelyx, Inc.
$33
Medtronic, Inc.
$32
Regeneron Healthcare Solutions, Inc.
$26
Braintree Laboratories, Inc.
$22
GENZYME CORPORATION
$22
Merck Sharp & Dohme LLC
$20
Top 3 companies account for 47.2% of 2024 payments
All-time payments by company (2019-2024) ›
Takeda Pharmaceuticals U.S.A., Inc.
$843
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$842
AbbVie Inc.
$817
ABBVIE INC.
$780
Celgene Corporation
$542
Janssen Biotech, Inc.
$417
Lilly USA, LLC
$242
Intercept Pharmaceuticals, Inc.
$191
VIVUS LLC
$166
AIMMUNE THERAPEUTICS, INC.
$135
Sandoz Inc.
$122
Merck Sharp & Dohme LLC
$122
GENZYME CORPORATION
$106
INTERCEPT PHARMACEUTICALS, INC.
$84
Madrigal Pharmaceuticals
$83
Regeneron Healthcare Solutions, Inc.
$76
Celltrion USA Inc.
$57
Ardelyx, Inc.
$57
Ironwood Pharmaceuticals, Inc
$44
Braintree Laboratories, Inc.
$41
Ipsen Biopharmaceuticals, Inc
$39
Nestle HealthCare Nutrition Inc.
$38
Phathom Pharmaceuticals, Inc.
$36
Daiichi Sankyo Inc.
$32
Medtronic, Inc.
$32
Gilead Sciences, Inc.
$32
Merck Sharp & Dohme Corporation
$28
AMAG Pharmaceuticals, Inc.
$25
Boston Scientific Corporation
$23
Fresenius Kabi USA, LLC
$18
Horizon Therapeutics plc
$17
Lumendi LLC
$15
QOL Medical, LLC
$15
Organon LLC
$14
AbbVie, Inc.
$14
Ferring Pharmaceuticals Inc.
$13
RedHill Biopharma Inc.
$12
EVOKE PHARMA, INC.
$11
Romark Laboratories, LC
$3
Top 3 companies account for 40.5% of all-time payments
Associated products mentioned in payments ›
ALINIA · Aemcolo · CIMZIA · CREON · Creon · DIFICID · DILUMEN · DUPIXENT · ENTYVIO · EOHILIA · FERAHEME · GATTEX · GIMOTI · HUMIRA · HYRIMOZ · IBSRELA · IDACIO · INJECTAFER · INTERSTIM · IQIRVO · LINZESS · Linzess · MAVYRET · MOTEGRITY · OCALIVA · OMVOH · QSYMIA · Qsymia · RAYOS · RENFLEXIS · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUFLAVE · SUTAB · Sucraid · TREMFYA · TRULANCE · VEGZELMA · VIBERZI · VOQUEZNA · VOWST · XIFAXAN · ZENPEP · ZEPOSIA · ZYMFENTRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for student in an organized health care education/training program in GA.

Looking for a student in an organized health care education/training program specialist in Atlanta?
Compare student in an organized health care education/training programs in the Atlanta area by procedure volume, costs, and industry payment transparency.
Browse student in an organized health care education/training programs nearby

Geographic Context

Student in an organized health care education/training programs within 10 mi
5,211
Per 100K population
487.7
County median income
$91,490
Nearest hospital
SAINT JOSEPH'S HOSPITAL OF ATLANTA, INC
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Clermont is a mixed practice specialist, with above-average Medicare volume (top 13% in GA), with low-engagement industry engagement in the top 6% of GA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Clermont experienced with infliximab infusion (remicade)?
Based on Medicare claims data, Dr. Clermont performed 990 infliximab infusion (remicade) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Clermont receive payments from pharmaceutical companies?
Yes. Dr. Clermont received a total of $6,182 from 39 companies across 352 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Clermont's costs compare to other student in an organized health care education/training programs in Atlanta?
Dr. Clermont's average Medicare payment per service is $51. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Clermont) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →